Cleerly Named Fierce Medtech’s “Fierce 15” Med Tech Companies of 2021
Organization recognizes venture-backed competitive companies championing innovation and creativity. New York, March 7, 2022 -- Cleerly, the company...
Cleerly is aware of the lawsuit filed by Heartflow. We are confident in our extensive and well-established intellectual property portfolio and the originality of our technology.
Cleerly has published landmark clinical science that has redefined how cardiovascular disease is understood and treated, which has formed the basis of our novel technologies that provide physicians with actionable insights into their patients’ heart health.
Cleerly was founded on a mission to create a world without heart attacks, and we have never been more focused in our mission and committed to the patients and physicians who count on us.
For any questions, please reach out to press@cleerlyhealth.com
Organization recognizes venture-backed competitive companies championing innovation and creativity. New York, March 7, 2022 -- Cleerly, the company...
Cleerly 2.2.0 includes UX updates and three high-value tools to better evaluate heart disease. New York, February 8, 2022 -- Cleerly, the company...
Organization recognizes the most promising and innovative health startups in New York. New York, February 2, 2022 -- Cleerly, the company creating a...
Cleerly Makes List of Most Innovative Digital Health Startups. New York, December 8, 2021 -- CB Insights today named Cleerly to its third annual...